| One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study P Faverio, F Luppi, P Rebora, G D’Andrea, A Stainer, S Busnelli, ... Respiratory Research 23 (1), 65, 2022 | 72 | 2022 |
| Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study G Sambataro, D Sambataro, L Spicuzza, F Meloni, G Lorini, L Malatino, ... Clin Exp Rheumatol 41 (5), 1140-8, 2023 | 17 | 2023 |
| Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study P Faverio, R Ronco, M Monzio Compagnoni, M Franchi, G Franco, ... Respiratory Research 24 (1), 70, 2023 | 8 | 2023 |
| Use of 6‐minute walk distance to predict lung transplant‐free survival in fibrosing non‐IPF interstitial lung diseases U Zanini, F Luppi, K Kaur, N Anzani, G Franco, G Ferrara, M Kalluri, ... Respirology 29 (5), 387-395, 2024 | 3 | 2024 |
| Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD R Ronco, G Franco, MM Compagnoni, S Aliberti, F Luppi, G Corrao, ... ERJ Open Research 9 (4), 2023 | 2 | 2023 |
| Idiopathic pulmonary fibrosis mortality in the Italian epicenter of COVID-19 pandemic P Faverio, S Conti, F Madotto, G Franco, E Renzoni, LG Mantovani, ... Pulmonology 29 (1), 85, 2022 | 2 | 2022 |
| Cardiovascular Structural and Functional Parameters in Idiopathic Pulmonary Fibrosis at Disease Diagnosis P Faverio, A Maloberti, P Rebora, RCM Intravaia, C Tognola, G Toscani, ... High Blood Pressure & Cardiovascular Prevention, 1-9, 2024 | 1 | 2024 |
| Lack of efficacy of tocilizumab in acute exacerbation of pulmonary fibrosis G Franco, P Le Guen, M Le Brun, Q Philippot, C Dupin, MP Debray, ... ERJ Open Research 10 (6), 2024 | | 2024 |
| Cystic lung in sarcoidosis: Clinico‐radiologic characteristic and evolution G Franco, MP Debray, N Anzani, A Marruchella, A Cazes, P Le Guen, ... Respirology 29 (12), 1067-1076, 2024 | | 2024 |
| Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers F Luppi, A Manfredi, P Faverio, G Franco, C Salvarani, E Bendstrup, ... Autoimmunity Reviews, 103668, 2024 | | 2024 |
| Evaluation of preoperative cardiopulmonary reserve and surgical risk of patients undergoing lung cancer resection F Petrella, A Cara, EM Cassina, P Faverio, G Franco, L Libretti, ... Therapeutic Advances in Respiratory Disease 18, 17534666241292488, 2024 | | 2024 |
| Percent Predicted vs. Absolute Six-Minute Walk Distance as Predictors of Lung Transplant-Free Survival in Fibrosing Interstitial Lung Diseases U Zanini, J Ding, F Luppi, K Kaur, N Anzani, G Franco, G Ferrara, ... Lung, 1-8, 2024 | | 2024 |
| Therapeutic Management of Bronchiectasis in Children and Adolescents: A Concise Narrative Review P Faverio, G Franco, V Landoni, M Nadalin, D Negri, A Tagliabue, ... Journal of Clinical Medicine 13 (16), 4757, 2024 | | 2024 |
| Coexistence of Eosinophilic Granulomatosis With Polyangiitis and Allergic Bronchopulmonary Aspergillosis: A Fascinating Relationship AM Marra, P Curci, G Franco, G Pittalis, E Tugnoli, D Cavasin, A Cristiano, ... Cureus 16 (4), 2024 | | 2024 |
| Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study P Curci, P Faverio, R Ronco, MM Compagnoni, M Franchi, G Franco, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
